Fastenal’s balance sheet is rock-solid. Its net leverage, measured through the net debt/EBITDA ratio, hovers around zero, which is considerably lower than the other industrial distributors we cover.

These steps prevent, rather than heal, costly losses that weaken a company’s cash position, especially in turbulent times.

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

UnitedHealth has dropped nearly 50% amid headwinds, but strong fundamentals, margin stability, and low valuation signal ...